Delivery Order SPE2DB24D2213-SPE2DB24FGVKB
Award Date
7/26/24
Potential Completion Date
7/29/24
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 syringes. The contract has a ceiling value of $7,946.07 and an ultimate completion date of September 18, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded numerous federal contracts to provide a wide range of...
This is a $10,784.33 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML and has an ultimate completion date of April 29, 2024. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 syringes. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $11,884.75 and a performance period through May 29, 2025. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Gardasil 9 syringes. The contract has a ceiling value of $13,101.03 and an ultimate completion date of August 23, 2022. It is a firm fixed-price contract. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The company holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the...
This is a $27,366.39 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of August 1, 2024 and is not set aside for any special categories of contractors. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $24,219.51 and an ultimate completion date of August 2, 2024. The contract is a Firm Fixed Price type and has no set-aside designation. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $76,416.04 firm fixed price contract is for the supply of GARDASIL 9 syringes, a vaccine product, with an ultimate completion date of August 21, 2024. The contract is not set aside for any small business designation. AmerisourceBergen is one of the largest pharmaceutical distributors in the U.S. and has numerous indefinite delivery contracts (IDCs) with federal...
This is a delivery order awarded to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. The award has a ceiling value of $6,509.96 and an ultimate completion date of August 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The order is for the supply of GARDASIL 9 syringes at a potential value of $15,150.87 and has a completion date of March 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 syringes, a vaccine product, with a ceiling value of $19,020.40. The contract has a firm fixed-price pricing type and an ultimate completion date of June 17, 2025. There is no set-aside designation, indicating this was an open competition. AmerisourceBergen Drug Corp holds...